Top

BMC Complementary Medicine and Therapies

Published in:

Open Access 01-12-2015 | Research article

Bixa orellana leaf extract suppresses histamine-induced endothelial hyperpermeability via the PLC-NO-cGMP signaling cascade

Authors: Yoke Keong Yong, Hoe Siong Chiong, Muhd Nazrul Somchit, Zuraini Ahmad

Published in: BMC Complementary Medicine and Therapies | Issue 1/2015

Abstract

Background

Histamine is established as a potent inflammatory mediator and it is known to increased endothelial permeability by promoting gap formation between endothelial cells. Previous studies have shown that aqueous extract of Bixa orellana leaves (AEBO) exhibits antihistamine activity in vivo, yet the mechanism of its action on endothelial barrier function remains unclear. Therefore, the current study aimed to determine the protective effect of AEBO against histamine-induced hyperpermeability in vitro.

Methods

The endothelial protective effect of AEBO was assess using an in vitro vascular permeability assay kit. Human umbilical vein endothelial cells (HUVEC) were used in the current study. HUVEC were pre-treated with AEBO for 12 h before histamine induction. Vascular permeability was evaluated by the amount of FITC-dextran leakage into the lower chamber. In order to elucidate the mechanism of action of AEBO, phospholipase C (PLC) activity, intracellular calcium level, nitric oxide (NO) concentration, cyclic guanosine monophosphate (cGMP) production and protein kinase C (PKC) activity were determined following histamine challenge.

Results

Histamine-induced increased HUVEC permeability was significantly attenuated by pretreatment with AEBO in a time- and concentration-dependent manner. Upregulation of PLC activity caused by histamine in HUVEC was suppressed by pretreatment with AEBO. Pretreatment with AEBO also blocked the production of intracellular calcium induced by histamine in HUVEC. In addition, AEBO suppressed the NO-cGMP signaling cascade when HUVEC were challenged with histamine. Moreover, PKC activity was significantly abolished by pretreatment with AEBO in HUVEC under histamine condition.

Conclusion

In conclusion, the present data suggest that AEBO could suppress histamine-induced increased endothelial permeability and the activity may be closely related with the inhibition of the PLC-NO-cGMP signaling pathway and PKC activity.

Goddard LM, Iruela-Arispe ML. Cellular and molecular regulation of vascular permeability. Thromb Haemost. 2013;109:407–15.CrossRefPubMedPubMedCentral

Brodsky SV, Yamamoto T, Tada T, Kim B, Chen J, Kajiva F, et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol. 2002;282:F1140–9.CrossRefPubMed

Volk T, Kox W. Endothelium function in sepsis. Inflamm Res. 2000;49:185–98.CrossRefPubMed

Seifert R, Strasser A, Schneider EH, Neumann D, Dove S, Buschauer A. Molecular and cellular analysis of human histamine receptor subtypes. Trends Pharmacol Sci. 2013;34:33–58.CrossRefPubMed

Rozenberg I, Sluka SHM, Rohrer L, Hofmann J, Becher B, Akhmedov A, et al. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoprotein. Arterioscler Thromb Vasc Biol. 2010;30:923–30.CrossRefPubMed

Buchan KW, Martin W. Modulation of barrier function of bovine aortic and pulmonary artery endothelial cells: dissociation from cytosolic calcium content. Br J Pharmacol. 1992;107:932–8.CrossRefPubMedPubMedCentral

Bull HA, Courtney PF, Rustin MH, Dowd PM. Characterization of histamine receptor sub-types regulating prostacyclin release from human endothelial cells. Br J Pharmacol. 1992;107:276–81.CrossRefPubMedPubMedCentral

Yuan Y, Granger HJ, Zawieja DC, DeFily DV, Chilian WM. Histamine increases venular permeability via a phospholipase C – NO synthase – guanylate cyclase cascade. Am J Physiol. 1993;264:H1734–9.PubMed

Shilpi JA, Taufiq-Ur-Rahman M, Uddin SJ, Alam MS, Sadhu SK, Seidel V. Preliminary pharmacological screening of Bixa orellana L. leaves. J Ethnopharmacol. 2006;108:264–71.CrossRefPubMed

10.

Braga FG, Bouzada MLM, Fabri RL, Matos MO, Moreira FO, Scio E, et al. Antileishmanial and antifungal activity of plants used in traditional medicine in Brazil. J Ethnopharmacol. 2007;111:396–402.CrossRefPubMed

11.

Yoke Keong Y, Arifah AK, Sukardi S, Roslida AH, Somchit MN, Zuraini A. Bixa orellana leaves extract inhibit bradykinin-induced inflammation via suppression of nitric oxide production. Med Princ Pract. 2011;20:142–6.CrossRefPubMed

12.

Yoke Keong Y, Zainul AZ, Arifah AK, Somchit MN, Cheng Lian GE, Zuraini A. Chemical constituents and antihistamine activity of Bixa orellana leaf extract. BMC Complement Altern Med. 2013;13:32.CrossRef

13.

Yoke Keong Y, NurShahira S, Nazrul MH, Cheng Lian GE, Zainul AZ, Fauziah O, et al. Suppressions of serotonin-induced increased vascular permeablity and leukocyte infiltration by Bixa orellana leaf extract. Biomed Res Int. 2013;2013:463145.

14.

Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca²⁺ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440–50.PubMed

15.

Chandra A, Angle N. VEGF inhibits PDGF-stimulated calcium signaling independent of phospholipase C and protein kinase C. J Surg Res. 2006;131:302–9.CrossRefPubMed

16.

Martins-Green M, Petreaca M, Yao M. An assay system for in vitro detection of permeability in human endothelium. Methods Enzymol. 2008;443:137–53.CrossRefPubMed

17.

Shrivastava-Ranjan P, Rollin PE, Spiropoulou CF. Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J Virol. 2010;84:11227–34.CrossRefPubMedPubMedCentral

18.

Yosef N, Ubogu EE. An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies. Cell Mol Neurobiol. 2013;33:175–86.CrossRefPubMed

19.

Jutel M, Akdis M, Akdis CA. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy. 2009;39:1786–800.CrossRefPubMed

20.

Rhee SG. Regulation of phosphoinositide-specific phospholipase C*. Annu Rev Biochem. 2001;70:281–312.CrossRefPubMedPubMedCentral

21.

Tiruppathi C, Minshall RD, Paria BC, Vogel SM, Malik AB. Role of Ca²⁺ signaling in the regulation of endothelial permeability. Vascul Pharmacol. 2002;39:173–85.CrossRefPubMed

22.

Yamada Y, Furumichi T, Furui H, Yokoi T, Ito T, Yamauchi K, et al. Roles of calcium, cyclic nucleotides, and protein kinase C in regulation of endothelial permeability. Arterioscler Thromb Vasc Biol. 1990;10:410–20.CrossRef

23.

Sandoval R, Malik AB, Minshall BD, Kouklis P, Ellis CA, Tiruppathi C. Ca²⁺ signaling and PKCα activate increased endothelial permeability by disassembly of VE-cadherin junctions. J Physiol. 2001;533:433–45.CrossRefPubMedPubMedCentral

24.

Wang Z, Ginnan R, Abdullaev IF, Trebak M, Vincent PA, Singer HA. Calcium/calmodulin-dependent protein kinase II delta 6 (CaMKIIδ₆) and RhoA involvement in thrombin-induced endothelial barrier dysfunction. J Biol Chem. 2010;285:21303–12.CrossRefPubMedPubMedCentral

25.

Tiruppathi C, Freichel M, Vogel SM, Paria BC, Mehta D, Flockerzi V, et al. Impairment of store-operated Ca²⁺ entry in TRPC4^−/− mice interferes with increase in lung microvascular permeability. Circ Res. 2002;91:70–6.CrossRefPubMed

26.

Huang Q, Yuan Y. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol. 1997;273:H2442–51.PubMed

27.

LaI BK, Varma S, Pappas PJ, Hobson RW, Durán WN. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvasc Res. 2001;62:252–62.CrossRef

28.

Varma S, Breslin JW, Lal BK, Pappas PJ, Hobson RW, Durán WN. P42/22 (MAPK) regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells. Microvasc Res. 2002;63:172–8.CrossRefPubMed

29.

Breslin JW, Pappas PJ, Cerveira JJ, Hobson RW, Durán WN. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol. 2003;248:H92–100.CrossRef

30.

Van Nieuw Amerongen GP, van Hinsbergh VW. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol. 2002;39:257–72.CrossRefPubMed

31.

Sabrane K, Kruse MN, Fabritz L, Zetsche B, Mitko D, Skryabin BV, et al. Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J Clin Invest. 2005;115:1666–74.CrossRefPubMedPubMedCentral

32.

Wong D, Dorovini-Zis K, Vincent SR. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood–brain barrier. Exp Neurol. 2004;190:446–55.CrossRefPubMed

33.

Yuan SY. Signal transduction pathways in enhanced microvascular permeability. Microcirculation. 2000;7:395–403.CrossRefPubMed

34.

Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006;86:279–367.CrossRefPubMed

35.

Murakami T, Frey T, Lin C, Antonetti DA. Protein kinase Cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo. Diabetes. 2012;61:1573–83.CrossRefPubMedPubMedCentral

36.

Northover AM, Northover BJ. Stimulation of protein kinase C activity may increase microvascular permeability to colloidal carbon via alpha-isoenzyme. Inflammation. 1994;18:481–7.CrossRefPubMed

37.

Willis CL, Meske DS, Davis TP. Protein kinase C activation modulates reversible increase in cortical blood–brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab. 2010;30:1847–59.CrossRefPubMedPubMedCentral

38.

Aveleira CA, Lin CM, Abcouwer SF, Ambrósio AF, Antonetti DA. TNF-α signals through PKCζ/NF-kB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes. 2010;59:2872–82.CrossRefPubMedPubMedCentral

39.

Aramoto H, Breslin JW, Pappas PJ, Hobson II RW, Durán WN. Vascular endothelial growth factor stimulats differential signaling pathways in vivo microcirculation. Am J Physiol Heart Circ Physiol. 2004;287:H1590–8.CrossRefPubMed

Title: Bixa orellana leaf extract suppresses histamine-induced endothelial hyperpermeability via the PLC-NO-cGMP signaling cascade
Authors: Yoke Keong Yong
Hoe Siong Chiong
Muhd Nazrul Somchit
Zuraini Ahmad
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: BMC Complementary Medicine and Therapies / Issue 1/2015
Electronic ISSN: 2662-7671
DOI: https://doi.org/10.1186/s12906-015-0901-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Bixa orellana leaf extract suppresses histamine-induced endothelial hyperpermeability via the PLC-NO-cGMP signaling cascade

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2015

Tetracarpidium conophorum ameliorates oxidative reproductive toxicity induced by ethanol in male rats

Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway

Inhibitory effect of Clitoria ternatea flower petal extract on fructose-induced protein glycation and oxidation-dependent damages to albumin in vitro

The effect of 3β, 6β, 16β-trihydroxylup-20(29)-ene lupane compound isolated from Combretum leprosum Mart. on peripheral blood mononuclear cells

Validation of ethnopharmacological uses of Murraya paniculata in disorders of diarrhea, asthma and hypertension

Monascus purpureus-fermented Thai glutinous rice reduces blood and hepatic cholesterol and hepatic steatosis concentrations in diet-induced hypercholesterolemic rats